Bioduct Srl, a Dedalus Group company, was founded in Italy in 2015. Since the beginning, our mission has been to provide safe, reliable, cost-effective solutions for the automatization of intravenous compounding, with specific focus on hazardous drugs.

Our Pharmoduct robot is the only automated solution for antiblastic drugs on the market to be CE marked as a Medical Device.

With a growing installed base and a focus on research and development to constantly expand the capabilities of Pharmoduct in terms of manageable drugs and final containers, our goal is to keep expanding that number, bringing the benefits of intravenous automation to more and more healthcare providers worldwide.